{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:08:42Z","timestamp":1774458522535,"version":"3.50.1"},"reference-count":30,"publisher":"Scientific Scholar","content-domain":{"domain":["ijdvl.com"],"crossmark-restriction":true},"short-container-title":["Indian J Dermatol Venereol Leprol"],"abstract":"\n Background<\/jats:title>\n The inflammatory markers (IMs) are a set of biomarkers used clinically to assess a patient for the presence of an active inflammatory disease or disease activity. They are elevated in conditions like infections, malignancies, mental illness and drug reactions among others.<\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n The study aimed at identifying the IMs that reflect the severity and recovery in severe cutaneous adverse drug reactions (SCARs).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A cross-sectional observational study was conducted among patients with SCARs (Stevens Johnson syndrome [SJS]\/ toxic epidermal necrolysis [TEN] and drug reaction with eosinophilia and systemic symptoms [DRESS]) admitted to a tertiary care hospital over 18 months.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Twenty SJS\/TEN and 8 DRESS cases were included in the study. There were more females in the study (F: M = 2:1). Comparing the IMs of SJS\/TEN and DRESS revealed that most markers on day 7 were lower as compared to day 0. There was a significant difference in eosinophil count (EC), procalcitonin (PCT) (p-value <0.05), and recovery time between the two groups. In the SJS\/TEN group, markers like ferritin (>2000 ng\/mL) and PCT (>2.0 ng\/mL) were significantly higher, around the septic range, in patients with concurrent connective tissue disease and culture positivity. Ferritin (p-value- 0.025, rho- 0.578), PCT (p-value- 0.013, rho- 0.239), and ESR (p-value- 0.041, rho- 0.482) were associated with the severity of SJS\/TEN. Patients with DRESS had an early recovery with a statistically significantly shorter hospital stay than SJS\/TEN (p<0.005). Baseline severity-of-illness score for TEN levels, total counts, and day 7 PCT significantly reflected the time taken for recovery.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n Marker analysis was performed at baseline and on day 7 of admission, but not after complete clinical recovery, therefore indicating a trend but limited conclusive behaviour of markers at the time of recovery.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The progression of IMs in a SCAR follows the clinical course of the illness. IMs like ferritin and PCT, along with routine haematological investigation, aid in identifying the severity, differentiating it among patients with comorbidities, and helping predict the recovery time in SCARs.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/ijdvl_1284_2024","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:46:47Z","timestamp":1749001607000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A cross-sectional analysis of inflammatory markers as a severity and prognostic indicator in severe cutaneous adverse drug reactions"],"prefix":"10.25259","volume":"92","author":[{"given":"Nayana","family":"Thara GS","sequence":"first","affiliation":[{"name":"Department of Dermatology, Goa Medical College, Panaji, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varadraj V","family":"Pai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Goa Medical College, Panaji, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Kadkol","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Goa Medical College, Panaji, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elreema","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Goa Medical College, Panaji, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Shulka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Goa Medical College, Panaji, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"10.25259\/IJDVL_1284_2024\/ref-1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0378-6323.74963","article-title":"Severe cutaneous adverse reactions","volume":"77","author":"Grover","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/idoj.idoj_196_21","article-title":"RegiSCAR DRESS (Drug reaction with eosinophilia and systemic symptoms) validation scoring system and Japanese consensus group criteria for atypical drug-induced hypersensitivity syndrome (DiHS): A comparative analysis","volume":"13","author":"Sasidharanpillai","year":"2022","journal-title":"Indian Dermatol Online J"},{"key":"10.25259\/IJDVL_1284_2024\/ref-3","article-title":"Physiology, acute phase reactants","volume-title":"StatPearls","author":"Gulhar","year":"2025"},{"key":"10.25259\/IJDVL_1284_2024\/ref-4","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.abd.2019.06.002","article-title":"Sepsis assessment in SJS\/TEN: An important point overlooked?","volume":"94","author":"Khurana","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-5","doi-asserted-by":"publisher","first-page":"2104755","DOI":"10.1155\/2022\/2104755","article-title":"Effect of serum ferritin on the prognosis of patients with sepsis: Data from the MIMIC-IV database","volume":"2022","author":"Fang","year":"2022","journal-title":"Emerg Med Int"},{"key":"10.25259\/IJDVL_1284_2024\/ref-6","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1038\/s41598-023-35874-2","article-title":"The relationship between serum ferritin level and clinical outcomes in sepsis based on a large public database","volume":"13","author":"He","year":"2023","journal-title":"Sci Rep"},{"key":"10.25259\/IJDVL_1284_2024\/ref-7","doi-asserted-by":"publisher","first-page":"e23043","DOI":"10.1002\/jcla.23043","article-title":"Association between serum ferritin and the severity of drug eruptions","volume":"34","author":"Pan","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.25259\/IJDVL_1284_2024\/ref-8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1346-8138.1990.tb01679.x","article-title":"Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis","volume":"17","author":"Mukai","year":"1990","journal-title":"J Dermatol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jamadermatol.2013.9944","article-title":"D-dimer levels as a marker of cutaneous disease activity: Case reports of cutaneous polyarteritis nodosa and atypical recurrent urticaria","volume":"150","author":"Kirchhof","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/CCID.S356450","article-title":"The correlation of neutrophil-lymphocyte ratio and eosinophil count with SCORTEN in SJS\/TEN","volume":"15","author":"Primisawitri","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00281-021-00868-7","article-title":"Eosinophils in skin diseases","volume":"43","author":"Radonjic-Hoesli","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-13","first-page":"28","article-title":"Dermatological adverse drug reactions due to systemic medications \u2013 A review of literature","volume":"16","author":"Dubey","year":"2017","journal-title":"J Pak Assoc Dermatol [Internet]."},{"key":"10.25259\/IJDVL_1284_2024\/ref-14","first-page":"16","article-title":"Prevalence of cutaneous drug eruption in hospitalized patients: A report from Sina Hospital of Tabriz","volume":"12","author":"Mitra","year":"2009","journal-title":"Iran J Dermatol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/0378-6323.132249","article-title":"Drug reaction with eosinophilia and systemic symptoms: Observations from a tertiary care institution","volume":"80","author":"Sasidharanpillai","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.4103\/njcp.njcp_122_16","article-title":"Drug-induced Stevens-Johnson syndrome in Indian population: A multicentric retrospective analysis","volume":"20","author":"Hirapara","year":"2017","journal-title":"Niger J Clin Pract"},{"key":"10.25259\/IJDVL_1284_2024\/ref-17","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): An interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.25259\/IJDVL_1284_2024\/ref-18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.anai.2019.06.017","article-title":"Procalcitonin as a diagnostic marker for differentiating DRESS syndrome from bacterial infection","volume":"123","author":"Rhyou","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ajem.2021.05.029","article-title":"Neutrophil-to-lymphocyte ratio is a prognostic predictor in emergency department patients with cutaneous adverse drug reaction","volume":"47","author":"Dundar","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.25259\/IJDVL_1284_2024\/ref-20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/diagnostics10110918","article-title":"Prevalence and impact of reported drug allergies among rheumatology patients","volume":"10","author":"Chan","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.25259\/IJDVL_1284_2024\/ref-21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jaci.2013.04.038","article-title":"Serum procalcitonin as a biomarker differentiating delayed-type drug hypersensitivity from systemic bacterial infection","volume":"132","author":"Yoon","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/archderm.143.12.1591-a","article-title":"High procalcitonin levels in patients with severe drug reactions","volume":"143","author":"Sfia","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.25259\/IJDVL_1284_2024\/ref-23","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1515\/cclm-2015-0772","article-title":"Marked elevation of procalcitonin in a patient with a drug related infusion reaction to rituximab","volume":"54","author":"Robier","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.25259\/IJDVL_1284_2024\/ref-24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3346\/jkms.2011.26.9.1147","article-title":"Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases","volume":"26","author":"Joo","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.25259\/IJDVL_1284_2024\/ref-25","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-4-s3-p94","article-title":"DRESS is a cause of increased serum procalcitonin level without bacterial infection","volume":"4","author":"Said","year":"2014","journal-title":"P94 Clinical & Translational All"},{"key":"10.25259\/IJDVL_1284_2024\/ref-26","doi-asserted-by":"publisher","first-page":"951714","DOI":"10.3389\/fmed.2022.951714","article-title":"Drug-induced hypersensitivity syndrome with high procalcitonin levels due to piperacillin\/tazobactam and meropenem: A case report","volume":"9","author":"Song","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.25259\/IJDVL_1284_2024\/ref-27","doi-asserted-by":"publisher","first-page":"100673","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: A literature review and treatment algorithm","volume":"16","author":"Calle","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.25259\/IJDVL_1284_2024\/ref-28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.burns.2021.11.004","article-title":"Impact of multiple medical interventions on mortality, length of hospital stay and reepithelialization time in toxic epidermal necrolysis, Steven-Johnsons syndrome, and TEN\/SJS overlap - metanalysis and metaregression of observational studies","volume":"48","author":"Krajewski","year":"2022","journal-title":"Burns"},{"key":"10.25259\/IJDVL_1284_2024\/ref-29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.burnso.2022.03.006","article-title":"Characteristics associated with disease prevalence, SCORTEN, length of stay, and mortality in hospitalized SJS\/TEN patients: A single-center, eleven-year experience","volume":"6","author":"Duplisea","year":"2022","journal-title":"Burns Open"},{"key":"10.25259\/IJDVL_1284_2024\/ref-30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.4168\/aair.2023.15.6.812","article-title":"RDW-SD and PCT are potential prognostic factors for in-hospital death in patients with Stevens-Johnson syndrome\/Toxic epidermal necrolysis","volume":"15","author":"Zhang","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.25259\/IJDVL_1284_2024\/ref-31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","article-title":"SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center","volume":"29","author":"Cartotto","year":"2008","journal-title":"J Burn Care Res"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijdvl.com\/a-cross-sectional-analysis-of-inflammatory-markers-as-a-severity-and-prognostic-indicator-in-severe-cutaneous-adverse-drug-reactions\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijdvl.com\/a-cross-sectional-analysis-of-inflammatory-markers-as-a-severity-and-prognostic-indicator-in-severe-cutaneous-adverse-drug-reactions\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T13:02:16Z","timestamp":1767358936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijdvl.com\/a-cross-sectional-analysis-of-inflammatory-markers-as-a-severity-and-prognostic-indicator-in-severe-cutaneous-adverse-drug-reactions\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":30,"alternative-id":["10.25259\/IJDVL_1284_2024"],"URL":"https:\/\/doi.org\/10.25259\/ijdvl_1284_2024","relation":{},"ISSN":["0973-3922","0378-6323"],"issn-type":[{"value":"0973-3922","type":"electronic"},{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"article-number":"22"}}